Nile Therapeutics strengthens scientific advisory board
In his role, Bristow will be overseeing the development of CD-NP, a dual natriuretic peptide receptor agonist in development for the treatment of acute decompensated heart failure. Nile
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.
ProVation MD replaces dictation and transcription and allows physicians to document procedures at the point of care, streamlines the coding and billing process and enhances compliance by producing
Cambia, a new water-soluble, buffered diclofenac potassium powder, is a prescription non-steroidal anti-inflammatory drug (NSAID) available for the acute treatment of migraine. The companies claimed that Cambia which